Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Ephedrine, caffeine and aspirin promote weight loss in obese subjects.

Krieger DR, Daly PA, Dulloo AG, Ransil BJ, Young JB, Landsberg L.

Trans Assoc Am Physicians. 1990;103:307-12. No abstract available.

PMID:
2132541
2.

Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.

Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S73-8.

PMID:
8384187
3.

Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese.

Dulloo AG, Miller DS.

Nutrition. 1989 Jan-Feb;5(1):7-9. Review. No abstract available.

PMID:
2520262
4.

Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.

Toubro S, Astrup AV, Breum L, Quaade F.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S69-72.

PMID:
8384186
5.

Pharmacology of thermogenic drugs.

Astrup A, Toubro S, Christensen NJ, Quaade F.

Am J Clin Nutr. 1992 Jan;55(1 Suppl):246S-248S. Review.

PMID:
1345887
6.
7.

The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.

Toubro S, Astrup A, Breum L, Quaade F.

Int J Obes Relat Metab Disord. 1993 Dec;17 Suppl 3:S73-7; discussion S82.

PMID:
8124407
8.

Herbal simulation of ephedrine and caffeine in treatment of obesity.

Dulloo AG.

Int J Obes Relat Metab Disord. 2002 May;26(5):590-2. Review. No abstract available.

PMID:
12032740
9.

Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.

Horton TJ, Geissler CA.

Int J Obes Relat Metab Disord. 1996 Feb;20(2):91-7.

PMID:
8646257
10.

The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.

Liu AG, Smith SR, Fujioka K, Greenway FL.

Obesity (Silver Spring). 2013 Oct;21(10):1991-6. doi: 10.1002/oby.20416. Epub 2013 Jun 11.

11.
12.
13.

[The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].

Quaade F, Astrup A, Breum L, Toubro S, Hein P.

Ugeskr Laeger. 1992 Apr 27;154(18):1258-63. Danish. No abstract available.

PMID:
1598695
14.

Acute and chronic cardiovascular and behavioural effects of caffeine, aspirin and ephedrine.

B├Ąttig K.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S61-4. Review. No abstract available.

PMID:
8384184
15.

[Letigen, insulin resistance and treatment of obesity].

Richelsen B.

Ugeskr Laeger. 2002 Aug 5;164(32):3794; author reply 3794. Danish. No abstract available.

PMID:
12362622
16.

Pharmaceutical cost savings of treating obesity with weight loss medications.

Greenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR.

Obes Res. 1999 Nov;7(6):523-31.

17.

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.

Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ, Quaade F.

Metabolism. 1992 Jul;41(7):686-8.

PMID:
1619985
18.

[Liberalized use of Letigen--how is the documentation?].

Astrup AV.

Ugeskr Laeger. 2002 Oct 14;164(42):4942-3; author reply 4943-4. Danish. No abstract available.

PMID:
12416080
19.

[Ephedrine and ephedra in weight loss products and other preparations].

van der Hooft CS, Stricker BH.

Ned Tijdschr Geneeskd. 2002 Jul 13;146(28):1335-6. Dutch.

PMID:
12148223
20.

Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.

Waluga M, Janusz M, Karpel E, Hartleb M, Nowak A.

Clin Physiol. 1998 Jan;18(1):69-76.

PMID:
9545623

Supplemental Content

Support Center